These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31127773)

  • 1. Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.
    Haddad M; Perrotte M; Landri S; Lepage A; Fülöp T; Ramassamy C
    J Alzheimers Dis; 2019; 69(3):751-762. PubMed ID: 31127773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients.
    Haddad M; Perrotte M; Ben Khedher MR; Madec E; Lepage A; Fülöp T; Ramassamy C
    J Alzheimers Dis; 2021; 84(1):227-237. PubMed ID: 34487040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia.
    Bär KJ; Franke S; Wenda B; Müller S; Kientsch-Engel R; Stein G; Sauer H
    Neurobiol Aging; 2003; 24(2):333-8. PubMed ID: 12498967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes.
    O'Grady KL; Khosla S; Farr JN; Bondar OP; Atkinson EJ; Achenbach SJ; Eckhardt BA; Thicke BS; Tweed AJ; Volkman TL; Drake MT; Hines JM; Singh RJ
    J Appl Lab Med; 2020 May; 5(3):558-568. PubMed ID: 32445362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
    Horie K; Miyata T; Yasuda T; Takeda A; Yasuda Y; Maeda K; Sobue G; Kurokawa K
    Biochem Biophys Res Commun; 1997 Jul; 236(2):327-32. PubMed ID: 9240434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pentosidine as an indicator of Alzheimer's disease.
    Meli M; Perier C; Ferron C; Parssegny F; Denis C; Gonthier R; Laurent B; Reynaud E; Frey J; Chamson A
    J Alzheimers Dis; 2002 Apr; 4(2):93-6. PubMed ID: 12214132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains.
    Takeda A; Wakai M; Niwa H; Dei R; Yamamoto M; Li M; Goto Y; Yasuda T; Nakagomi Y; Watanabe M; Inagaki T; Yasuda Y; Miyata T; Sobue G
    Acta Neuropathol; 2001 Jan; 101(1):27-35. PubMed ID: 11194938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
    Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
    Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease?
    Monacelli F; Borghi R; Pacini D; Serrati C; Traverso N; Odetti P
    Clin Chem Lab Med; 2014 Jan; 52(1):117-20. PubMed ID: 23612599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end-products in anterior chamber aqueous of cataractous patients.
    Franke S; Stein F; Dawczynski J; Blum M; Kubetschka U; Stein G; Strobel J
    J Cataract Refract Surg; 2003 Feb; 29(2):329-35. PubMed ID: 12648645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
    Thomas CJ; Cleland TP; Sroga GE; Vashishth D
    Bone; 2018 May; 110():128-133. PubMed ID: 29408699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of advanced glycation end products in human cataractous lenses.
    Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G
    J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated IgM against Nε-(Carboxyethyl)lysine-modified Apolipoprotein A1 peptide 141-147 in Taiwanese with Alzheimer's disease.
    Lin CY; Sheu JJ; Tsai IS; Wang ST; Yang LY; Hsu IU; Chang HW; Lee HM; Kao SH; Lee CK; Chen CH; Lin YF
    Clin Biochem; 2018 Jun; 56():75-82. PubMed ID: 29680706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration.
    Ni J; Yuan X; Gu J; Yue X; Gu X; Nagaraj RH; Crabb JW;
    Mol Cell Proteomics; 2009 Aug; 8(8):1921-33. PubMed ID: 19435712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of pathogenic proteins in total circulating extracellular vesicles in mild cognitive impairment and during the progression of Alzheimer's disease.
    Perrotte M; Haddad M; Le Page A; Frost EH; Fulöp T; Ramassamy C
    Neurobiol Aging; 2020 Feb; 86():102-111. PubMed ID: 31883770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.